Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: Implications for the control of proliferation

Placenta

Volumn 20, Issue 5-6, 1999, Pages 401-406

  Bamberger, A M ^a   Sudahl, S ^a   Bamberger, C M ^b   Schulte, H M ^b   Loning T ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; KI 67 ANTIGEN; PROTEIN P27;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST;

EID: 0033168384     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0396     Document Type: Article

References (34)

1. Bamberger AM, Riethdorf L, Milde-Langosch K, Bamberger CM, Thuneke I, Erdmann I, Schulte HM & Löning T (1999) Strongly reduced expression of the cell cycle inhibitor p27 in endometrial hyperplasia and carcinoma. Virchows Arch, 434, 423-428.
2. Blankenship TN & King BF (1994) Developmental expression of Ki-67 antigen and proliferating cell nuclear antigen in macaque placentas. Dev Dynamics, 201, 324-333.
3. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI & Slingerland JM (1997) Decreased levels of the cell-cycle inhibitor p27/KIP1 protein: Prognostic implications in primary breast cancer. Nature Med, 3, 227-230.
4. ink4. Mol Cell Biol, 15, 2682-2688.
5. Courjal F, Louason G, Speiser P, Katsaros D, Zeilinger R & Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer, 69, 247-253.
6. DeLoia JA, Burlingame JM & Krasnow JS (1997) Differential expression of G1 cyclins during human placentogenesis. Placenta, 18, 9-16.
7. Dulic V, Lees E & Reed SI (1992) Association of human cyclin E with a periodic G1-S-phase protein kinase. Science, 257, 1958-1961.
8. Kip1-deficient mice. Cell, 85, 733-744.
9. Gillett C, Ranti V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D & Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res, 54, 1812-1817.
10. Hung W-C, Chai C-Y, Huang J-S & Chuang L-Y (1996) Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors. Hum Pathol, 27, 1324-1328.
11. Hunter T & Pines J (1994) Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
12. Kip1. Cell, 85, 721-732.
13. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR & Roberts JM (1992) Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science, 257, 1689-1694.
14. Koh J, Enders GH, Dynlacht BD & Harlow E (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-510.
15. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM & Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal cancers. Nature Med, 3, 231-234.
16. Mayhew TM & Burton GJ (1997) Stereology and its impact on our understanding of human placental functional morphology. Microsc Res Tech, 38, 195-205.
17. Milde-Langosch K., Ocon E, Becker G & Löning T (1998) p16/MTS1 inactivation in ovarian carcinomas: High frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int J Cancer, 79, 61-65.
18. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K & Akiyoshi T (1997) p27 expression and gastric carcinoma. Nature Med, 3, 593.
19. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707-720.
20. Nikaido T, Li S, Shiozawa T & Fujii S (1996) Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer, 78, 1248-1253.
21. Pagano M, Tam SW, Theodorras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF & Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
22. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM & Koff A (1994a) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev, 8, 9-22.
23. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P & Massague J (1994b) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
24. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR & Roberts JM (1997) Expression of cell-cycle regulators p27/KIP1 and cyclin E, alone or in combination, correlate with survival in young breast cancer patients. Nature Med, 3, 222-225.
25. Quesnel B, Fenaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C & Peyrat JP (1995) Analysis of the p16 gene deletion and point mutation in breast carcinoma. Br J Cancer, 72, 351-353.
26. Shapiro GI & Rollins BJ (1996) p16INK4a as a human tumor suppressor. Biochim Biophys Acta, 1242, 165-169.
27. Sherr CJ (1994) G1 phase progression: Cycling on cue. Cell, 79, 551-555.
28. Sherr CJ & Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev, 9, 1149-1163.
29. Shih I-M & Kurman RJ (1997) New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. Verh Dtsch Ges Pathol, 81, 266-272.
30. Sicinski P, Dohaner JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ & Weinberg RA (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82, 621-630.
31. Steeg PS & Abrams JS (1997) Cancer prognostics: Past, present and p27. Nature Med, 3, 152-154.
32. Toyoshima H & Hunter T (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
33. Wolf HK & Michalopoulos GK (1992) Proliferating cell nuclear antigen in human placenta and trophoblastic disease. Pediatr Pathol, 12, 147-154.
34. Yang R, Gombart AF, Serrano M & Koeffler HP (1995) Mutational effects on the p16INK4a tumor suppressor protein. Cancer Res, 55, 2503-2506.